HomeNMRA • NASDAQ
add
Neumora Therapeutics Inc
Previous close
$9.69
Day range
$9.52 - $9.89
Year range
$8.33 - $21.00
Market cap
1.56B USD
Avg Volume
1.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 76.65M | 34.79% |
Net income | -72.55M | -36.81% |
Net profit margin | — | — |
Earnings per share | -0.45 | 60.53% |
EBITDA | -76.49M | -34.92% |
Effective tax rate | -0.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 341.31M | -33.02% |
Total assets | 352.54M | -35.28% |
Total liabilities | 31.80M | -0.80% |
Total equity | 320.74M | — |
Shares outstanding | 161.56M | — |
Price to book | 4.84 | — |
Return on assets | -50.62% | — |
Return on capital | -54.10% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -72.55M | -36.81% |
Cash from operations | -33.48M | 29.91% |
Cash from investing | 156.99M | 559.20% |
Cash from financing | 1.53M | -99.34% |
Net change in cash | 125.04M | -39.91% |
Free cash flow | -8.94M | 69.94% |
About
Founded
2019
Headquarters
Website
Employees
109
